Efficacy and Safety of Sofosbuvir-Based Direct Acting Antivirals for Hepatitis C in Septuagenarians and Octogenarians

BACKGROUND/AIMS: Treatment of chronic hepatitis C (HCV) with newer direct acting antiviral (DAA) agents has been highly effective. Unfortunately, patients over 70 years old are underrepresented in studies. Given current recommendations to screen patients born between 1945 and 1965 for HCV, it is ess...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Exp Hepatol
Auteurs principaux: Snyder, Heather S., Ali, Bilal, Gonzalez, Humberto C., Nair, Satheesh, Satapathy, Sanjaya K.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478933/
https://ncbi.nlm.nih.gov/pubmed/28663671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.03.009
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires